De Meerleer G - Search Results

1

De Wever O, Derycke L, Hendrix A, De Meerleer G, Godeau F, Depypere H, Bracke M. De Wever O, et al. Among authors: de meerleer g. Clin Exp Metastasis. 2007;24(8):685-97. doi: 10.1007/s10585-007-9104-8. Epub 2007 Oct 19. Clin Exp Metastasis. 2007. PMID: 17952616 Review.

2

A qualitative approach to combined magnetic resonance imaging and spectroscopy in the diagnosis of prostate cancer.

Villeirs GM, Oosterlinck W, Vanherreweghe E, De Meerleer GO. Villeirs GM, et al. Eur J Radiol. 2010 Feb;73(2):352-6. doi: 10.1016/j.ejrad.2008.10.034. Epub 2008 Dec 11. Eur J Radiol. 2010. PMID: 19084363

3

Screening and early diagnosis of prostate cancer: an update.

Lumen N, Fonteyne V, De Meerleer G, De Visschere P, Ost P, Oosterlinck W, Villeirs G. Lumen N, et al. Among authors: de meerleer g, de visschere p. Acta Clin Belg. 2012 Jul-Aug;67(4):270-5. doi: 10.2143/ACB.67.4.2062671. Acta Clin Belg. 2012. PMID: 23019802 Review.

4

Early biomarkers related to secondary primary cancer risk in radiotherapy treated prostate cancer patients: IMRT versus IMAT.

Werbrouck J, Ost P, Fonteyne V, De Meerleer G, De Neve W, Bogaert E, Beels L, Bacher K, Vral A, Thierens H. Werbrouck J, et al. Among authors: de meerleer g, de neve w. Radiother Oncol. 2013 Jun;107(3):377-81. doi: 10.1016/j.radonc.2013.05.014. Epub 2013 Jun 19. Radiother Oncol. 2013. PMID: 23791364 Free article.

5

Androgen Receptor Gene Copy Number and Protein Expression in Treatment-Naïve Prostate Cancer.

Poelaert F, Kumps C, Lumen N, Verschuere S, Libbrecht L, Praet M, Rottey S, Claeys T, Ost P, Decaestecker K, De Meerleer G, Van Praet C. Poelaert F, et al. Among authors: de meerleer g. Urol Int. 2017;99(2):222-228. doi: 10.1159/000455158. Epub 2017 Jan 5. Urol Int. 2017. PMID: 28052297

6

Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients.

Villeirs GM, De Meerleer GO, De Visschere PJ, Fonteyne VH, Verbaeys AC, Oosterlinck W. Villeirs GM, et al. Eur J Radiol. 2011 Feb;77(2):340-5. doi: 10.1016/j.ejrad.2009.08.007. Epub 2009 Sep 8. Eur J Radiol. 2011. PMID: 19740617

7

Imaging treated prostate cancer.

De Visschere PJ, Vargas HA, Ost P, De Meerleer GO, Villeirs GM. De Visschere PJ, et al. Among authors: de meerleer go. Abdom Imaging. 2013 Dec;38(6):1431-46. doi: 10.1007/s00261-013-9998-3. Abdom Imaging. 2013. PMID: 23604966 Review.

8

The role of androgen receptor expression in the curative treatment of prostate cancer with radiotherapy: a pilot study.

Poelaert F, Van Praet C, Beerens AS, De Meerleer G, Fonteyne V, Ost P, Lumen N. Poelaert F, et al. Among authors: de meerleer g. Biomed Res Int. 2015;2015:812815. doi: 10.1155/2015/812815. Epub 2015 Feb 22. Biomed Res Int. 2015. PMID: 25793207 Free PMC article.

9

The magnetic resonance detected intraprostatic lesion in prostate cancer: planning and delivery of intensity-modulated radiotherapy.

De Meerleer G, Villeirs G, Bral S, Paelinck L, De Gersem W, Dekuyper P, De Neve W. De Meerleer G, et al. Among authors: de gersem w, de neve w. Radiother Oncol. 2005 Jun;75(3):325-33. doi: 10.1016/j.radonc.2005.04.014. Radiother Oncol. 2005. PMID: 15967524

10

Interobserver delineation variation using CT versus combined CT + MRI in intensity-modulated radiotherapy for prostate cancer.

Villeirs GM, Van Vaerenbergh K, Vakaet L, Bral S, Claus F, De Neve WJ, Verstraete KL, De Meerleer GO. Villeirs GM, et al. Strahlenther Onkol. 2005 Jul;181(7):424-30. doi: 10.1007/s00066-005-1383-x. Strahlenther Onkol. 2005. PMID: 15995835

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page